131 related articles for article (PubMed ID: 38936838)
1. Antifungal efficacy of natural antiseptic products against Candida auris.
Wu WG; Luk KS; Hung MF; Tsang WY; Lee KP; Lam BH; Cheng KL; Cheung WS; Tang HL; To WK
Med Mycol; 2024 Jun; ():. PubMed ID: 38936838
[TBL] [Abstract][Full Text] [Related]
2. Augmenting the Activity of Chlorhexidine for Decolonization of
Johnson CJ; Eix EF; Lam BC; Wartman KM; Meudt JJ; Shanmuganayagam D; Nett JE
J Fungi (Basel); 2021 Sep; 7(10):. PubMed ID: 34682225
[No Abstract] [Full Text] [Related]
3. Efficacy of octenidine- and chlorhexidine-based wash-mitts against Candida albicans and Candida auris - a comparative study.
Gugsch F; Tan CK; Oh DY; Paßvogel L; Steinhauer K
J Hosp Infect; 2024 Jan; 143():91-96. PubMed ID: 37949371
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris.
Chesnay A; Bailly É; Desoubeaux G
J Mycol Med; 2021 Dec; 31(4):101173. PubMed ID: 34271481
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of pathogenicity for the emerging fungus Candida auris.
Horton MV; Holt AM; Nett JE
PLoS Pathog; 2023 Dec; 19(12):e1011843. PubMed ID: 38127686
[TBL] [Abstract][Full Text] [Related]
6. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris.
Moore G; Schelenz S; Borman AM; Johnson EM; Brown CS
J Hosp Infect; 2017 Dec; 97(4):371-375. PubMed ID: 28865738
[TBL] [Abstract][Full Text] [Related]
7. In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris.
Tran HNH; Graham L; Adukwu EC
Appl Microbiol Biotechnol; 2020 Oct; 104(20):8911-8924. PubMed ID: 32880694
[TBL] [Abstract][Full Text] [Related]
8. The comparative efficacy of antiseptics against Candida auris biofilms.
Kean R; McKloud E; Townsend EM; Sherry L; Delaney C; Jones BL; Williams C; Ramage G
Int J Antimicrob Agents; 2018 Nov; 52(5):673-677. PubMed ID: 29775686
[TBL] [Abstract][Full Text] [Related]
9. Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris.
Barreto TL; Rossato L; de Freitas ALD; Meis JF; Lopes LB; Colombo AL; Ishida K
Int J Antimicrob Agents; 2020 Aug; 56(2):106049. PubMed ID: 32544569
[TBL] [Abstract][Full Text] [Related]
10.
Ku TSN; Walraven CJ; Lee SA
Front Microbiol; 2018; 9():726. PubMed ID: 29706945
[No Abstract] [Full Text] [Related]
11. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
[TBL] [Abstract][Full Text] [Related]
12. Broad susceptibility of
Lohse MB; Laurie MT; Levan S; Ziv N; Ennis CL; Nobile CJ; DeRisi J; Johnson AD
mBio; 2023 Aug; 14(4):e0137623. PubMed ID: 37493629
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of Caryocar brasiliense camb. Alone or along with antifungal agents against multidrug-resistant Candida auris.
Retore YI; Lucini F; Rial RC; Cardoso CAL; Souza PFN; Simionatto S; Rossato L
J Ethnopharmacol; 2024 Aug; 330():118240. PubMed ID: 38677574
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the
Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
Microbiol Spectr; 2021 Dec; 9(3):e0139521. PubMed ID: 34730380
[TBL] [Abstract][Full Text] [Related]
15. Withania somnifera seed oil exhibits antibiofilm properties against drug-resistant Candida auris clinical isolate through modulation in cell permeability.
Balkrishna A; Kharayat B; Rastogi S; Kabdwal M; Haldar S; Varshney A
J Appl Microbiol; 2023 Jun; 134(6):. PubMed ID: 37096387
[TBL] [Abstract][Full Text] [Related]
16. Antifungal Activity of a Medical-Grade Honey Formulation against
de Groot T; Janssen T; Faro D; Cremers NAJ; Chowdhary A; Meis JF
J Fungi (Basel); 2021 Jan; 7(1):. PubMed ID: 33450974
[No Abstract] [Full Text] [Related]
17. Liposomal formulation of a new antifungal hybrid compound provides protection against
Jaromin A; Zarnowski R; Markowski A; Zagórska A; Johnson CJ; Etezadi H; Kihara S; Mota-Santiago P; Nett JE; Boyd BJ; Andes DR
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0095523. PubMed ID: 38092678
[TBL] [Abstract][Full Text] [Related]
18. Investigating Dual-Species
Gülmez D; Brown JL; Butcher MC; Delaney C; Kean R; Ramage G; Short B
Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884184
[No Abstract] [Full Text] [Related]
19. Host defense mechanisms against
Pechacek J; Lionakis MS
Expert Rev Anti Infect Ther; 2023; 21(10):1087-1096. PubMed ID: 37753840
[TBL] [Abstract][Full Text] [Related]
20. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris.
Abdolrasouli A; Armstrong-James D; Ryan L; Schelenz S
Mycoses; 2017 Nov; 60(11):758-763. PubMed ID: 28872735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]